By Thierry Malleret, economist

By Thierry Malleret, economist

Big tech is at the forefront of the fight against the inevitability of aging. A handful of start-ups like Arivale, Metabolic Code, Color Genomics and Forward (and there are many others…) are now in the business of optimizing health by harnessing the power of predictive analytics through in-depth analysis of an individual’s genetics, physiology and psychology.

Their claim is that this approach will soon become the normal standard of care with personalized/high tech medicine accessible for all. Maybe, but for the moment the cost of such an approach (up to $40,000 per year) makes it the preserve of the ultra-wealthy. As such, despite the extraordinary promise it holds for the future, in the near future it is bound to increase inequalities even further.

Posted
AuthorBeth McGroarty, Director of Research, GWI